Pharmafile Logo

Why we need to look at rare diseases in a different way

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.

- PMLiVE - PMLiVE

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives. But why is this important?  If rare diseases are rare, why should we be interested, make time to care, learn more or more importantly take action?

Critically, although we define individual rare diseases as rare, collectively there are around 7,000 which means that 1 in 17 of us will suffer from a rare disease in our lifetimes, equivalent to 7% of the population.

As Su Smith, Director of Origins Insights, explains, “although medics classify certain conditions as rare. For the people that live with the condition, they aren’t rare to them. They live with it, manage it and treat it every day.”

The lack of awareness and information, challenges to diagnose rare diseases, as well as the lack of effective treatments and support services mean those living with a rare condition can often feel isolated, marginalised and misunderstood. So maybe we need to change our perspectives of rare diseases and think about them differently.

“If we could see rare disease, and the understanding of the basic biology of rare disease, as a doorway, an opening to understanding much bigger healthcare challenges, and finding solutions and cures to a range of more common diseases, that’s really where rare could change the world,” is the forward-thinking opinion of Jo Balfour, Managing Director of the Cambridge Rare Disease Network.

To help raise awareness of rare diseases, Bedrock Healthcare Communications and Origins Insights have worked together to develop a short film, ‘What One Thing….’ to uncover insights from the rare disease community including patients, providers, researchers, support networks and the pharmaceutical industry on the challenges, the changes needed and their hopes for the future.

Commenting on the film, Marie Little, Managing Director of Bedrock Healthcare Communications says, “Curiosity is at the heart of our thinking at Bedrock. Blending this with insights, creativity and science means that we can help to improve the lives of people with rare diseases”.

To view ‘What one Thing’ please visit https://bedrock-health.com/rdd/

For more information about Bedrock Healthcare Communications please visit www.bedrock-health.com

For more information about Origins insights please visit www.origins-insights.com

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

The value medical communications bring to phase 2/3 of drug development

Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services

Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

The award recognises outstanding achievement in flexing thinking and processes to ensure success.